BIOMAT Database Logo BIOMAT Database Logo

Nephrotoxicity associated with combined gentamicin-amphotericin B therapy. 1977

D N Churchill, and J Seely

The administration of a low total dose of amphotericin B to four consecutive patients already receiving gentamicin resulted in a deterioration of renal function in all. No other cause of the renal dysfunction was apparent in three cases. It appears probable that these drugs exhibit synergistic nephrotoxicity.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009393 Nephritis Inflammation of any part of the KIDNEY. Nephritides
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone

Related Publications

D N Churchill, and J Seely
The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy.
November 2001, The American journal of medicine,
D N Churchill, and J Seely
Risk factors for nephrotoxicity associated with conventional amphotericin B therapy.
September 2002, The American journal of medicine,
D N Churchill, and J Seely
[Nephrotoxicity of combined therapy with cephalothin and gentamicin].
October 1976, Ugeskrift for laeger,
D N Churchill, and J Seely
Nephrotoxicity associated with amphotericin B deoxycholate in neonates.
December 2009, The Pediatric infectious disease journal,
D N Churchill, and J Seely
Reduction of nephrotoxicity associated with amphotericin B deoxycholate.
January 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
D N Churchill, and J Seely
Nephrotoxicity in combined cephalothin and gentamicin therapy.
January 1977, Acta medica Scandinavica,
D N Churchill, and J Seely
Amphotericin B nephrotoxicity.
August 1988, American family physician,
D N Churchill, and J Seely
Amphotericin B nephrotoxicity.
January 1990, Drug safety,
D N Churchill, and J Seely
Amphotericin B nephrotoxicity.
January 2002, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
D N Churchill, and J Seely
Amphotericin B nephrotoxicity.
February 2002, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!